1. Home
  2. UFPT vs AGIO Comparison

UFPT vs AGIO Comparison

Compare UFPT & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFPT
  • AGIO
  • Stock Information
  • Founded
  • UFPT 1963
  • AGIO 2007
  • Country
  • UFPT United States
  • AGIO United States
  • Employees
  • UFPT N/A
  • AGIO N/A
  • Industry
  • UFPT Medical/Dental Instruments
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • UFPT Health Care
  • AGIO Health Care
  • Exchange
  • UFPT Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • UFPT 1.6B
  • AGIO 1.4B
  • IPO Year
  • UFPT 1993
  • AGIO 2013
  • Fundamental
  • Price
  • UFPT $236.48
  • AGIO $27.32
  • Analyst Decision
  • UFPT Buy
  • AGIO Buy
  • Analyst Count
  • UFPT 2
  • AGIO 8
  • Target Price
  • UFPT $392.00
  • AGIO $56.00
  • AVG Volume (30 Days)
  • UFPT 124.8K
  • AGIO 524.5K
  • Earning Date
  • UFPT 05-06-2025
  • AGIO 05-01-2025
  • Dividend Yield
  • UFPT N/A
  • AGIO N/A
  • EPS Growth
  • UFPT 31.41
  • AGIO N/A
  • EPS
  • UFPT 8.15
  • AGIO 11.45
  • Revenue
  • UFPT $547,560,000.00
  • AGIO $37,035,000.00
  • Revenue This Year
  • UFPT $18.91
  • AGIO $40.62
  • Revenue Next Year
  • UFPT $7.77
  • AGIO $216.26
  • P/E Ratio
  • UFPT $29.03
  • AGIO $2.39
  • Revenue Growth
  • UFPT 34.43
  • AGIO 25.96
  • 52 Week Low
  • UFPT $178.26
  • AGIO $23.42
  • 52 Week High
  • UFPT $366.41
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • UFPT 65.34
  • AGIO 41.34
  • Support Level
  • UFPT $193.13
  • AGIO $27.78
  • Resistance Level
  • UFPT $225.43
  • AGIO $31.55
  • Average True Range (ATR)
  • UFPT 11.98
  • AGIO 1.38
  • MACD
  • UFPT 3.55
  • AGIO -0.03
  • Stochastic Oscillator
  • UFPT 98.70
  • AGIO 2.98

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: